Parental history of hypertension is associated with coagulation- fibrinolytic balance disorders

Thrombosis Research

Volumn 111, Issue 1-2, 2003, Pages 45-49

  Makris, Thomas K ^a   Stavroulakis, George A ^a   Hatzizacharias, Antonios N ^a   Krespi, Panagiota G ^a   Margos, Panagiotis ^a   Tsoukala, Caterina ^a   Mandalaki, Titika ^a   Votteas, Vassilios V ^a  

^a KAT HOSPITAL   (Greece)

Author keywords

Coagulation; Essential hypertension; Fibrinolysis; Offspring

Indexed keywords

BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 7; FIBRIN; FIBRINOGEN; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN S; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; FAMILY HISTORY; FEMALE; FIBRINOLYSIS; HEART RATE; HISTORY OF MEDICINE; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROGENY; PROTEIN DEGRADATION; SCHOOL CHILD; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

EID: 0344872756     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(03)00378-5     Document Type: Article

References (37)

1. Landin K., Tengborn L., Smith U. Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J. Intern. Med. 227(4):1990;273-278.
2. Poli K., Tofler G.H., Larson M.G., Evans J.C., Sutherland P.A., Lipinska I., et al. Association of blood pressure with fibrinolytic potential in the Framingham offspring population. Circulation. 101(3):2000;264-269.
3. Makris T.K., Tsoukala C., Krespi P., Hatzizacharias A., Gialeraki A., Papargyriou J., et al. Haemostasis balance disorders in patients with essential hypertension. Thromb. Res. 88(2):1997;99-107.
4. Jansson J.H., Johansson B., Boman K., Nilsson T.K. Hypo-fibrinolysis in patients with hypertension and elevated cholesterol. J. Intern. Med. 229(4):1991;309-316.
5. Pedrinelli R., Giampietro O., Carmassi F., Melillo E., Dell'Omo G., Catapano G., et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet. 344(8914):1994;14-18.
6. Lip G.Y., Blann A.D., Jones A.F., Lip P.L., Beevers D.G. Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. Am. J. Cardiol. 80(12):1997;1566- 1571.
7. Makris T. Thrombomodulin levels in patients with arterial hypertension. Am. J. Med. 103(4):1997;331-332.
8. Junker R., Heinrich J., Schulte H., Erren M., Assmann G. Hemostasis in normotensive and hypertensive men: results of the PROCAM study. J. Hypertens. 16(7):1998;917-923.
9. Mavrogiannis L., Kariyawasam K.P., Osmond D.H. Potent blood pressure raising effects of activated coagulation factor XII. Can. J. Physiol. Pharmacol. 75(12):1997;1398-1403.
10. Vague P., Juhan-Vague I., Aillaud M.F., Badier C., Viard R., Alessi M.C., et al. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism. 35(3):1986;250-253.
11. Wilhelmsen L., Svardsudd K., Korsan Bengtsen K., Larsson B., Welin L., Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N. Engl. J. Med. 311(8):1984;501-505.
12. Lee A.J., Lowe G.D., Woodward M., Tunstall-Pedoe H. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study. Br. Heart J. 69(4):1993;338-342.
13. Folsom A.R., Wu K.K., Rosamond W.D., Sharrett A.R., Chambless L.E. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 96(4):1997;1102-1108.
14. Thompson S.G., Kienast J., Pyke S.D., Haverkate F., van de Loo J.C. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N. Engl. J. Med. 332(10):1995;635-641.
15. Kienast J., Thompson S.G., Raskino C., Pelzer H., Fechtrup C., Ostermann H., et al. Prothrombin activation fragment 1+2 and thrombin antithrombin III complexes in patients with angina pectoris: relation to the presence and severity of coronary atherosclerosis. Thromb. Haemost. 70(4):1993;550-553.
16. Hamsten A., de Faire U., Walldius G., Dahlen G., Szamosi A., Landou C., et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 2:1987;3-9.
17. Ridker P.M., Vaughan D.E., Stampfer M.J., Manson J.E., Hennekens C.H. Endogenous tPA and risk of myocardial infarction. Lancet. 341(8854):1993;1165- 1181.
18. Horky K., Jackymova M., Jindra A., Savlikova J., Peleska J., Umnerova V., et al. Metabolic, humoral and haemodynamic characteristics of normotensive offspring from hypertensive families. J. Hum. Hypertens. 10(Suppl. 3):1996;S85-S87.
19. Lascaux-Lefebvre V., Ruidavets J., Arveiler D., Amouyel P., Haas B., Cottel D., et al. Influence of parental history of hypertension on blood pressure. J. Hum. Hypertens. 13(9):1999;631-636.
20. Palatini P., Julius S. Heart rate and the cardiovascular risk. J. Hypertens. 15(1):1997;3-17.
21. Makris T.K., Stavroulakis G.A., Krespi P.G., Hatzizacharias A.N., Kyriaki D.K., Chronakis E.V., et al. Elevated plasma immunoreactive leptin levels preexist in healthy offspring of patients with essential hypertension. Am. Heart J. 138(5 Part 1):1999;922-925.
22. Hausberg M., Sinkey C.A., Mark A.L., Hoffman R.P., Anderson E.A. Sympathetic nerve activity and insulin sensitivity in normotensive offspring of hypertensive patients. Am. J. Hypertens. 11(11 Part 1):1998;1312-1320.
23. Lopes H.F., Silva H.B., Soares J.A., Filho B., Consolim-Colombo F.M., Giorgi D.M., et al. Lipid metabolism alterations in normotensive subjects with positive family history of hypertension. Hypertension. 30(30 Part 2):1997;629-631.
24. Chen H.S., Hwu C.M., Kwok C.F., Shih K.C., Hsiao L.C., Lee S.H., et al. Insulin sensitivity in normotensive offspring of hypertensive parents. Horm. Metab. Res. 32(3):2000;110-114.
25. Endre T., Mattiasson I., Berntorp E., Berglund G., Hulthen U.L. Coagulation and fibrinolytic factors in normotensive hypertension-prone men. J. Hypertens. 14(5):1996;629-634.
26. Valek J., Valkova L., Vlasakova Z., Topinka V. Increased fibrinogen levels in the offspring of hypertensive men. Relation with hyperinsulinemia and the metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 15(12):1995;2229-2233.
27. Saltin B., Grimby G. Physiological analysis of middle-aged men and old former athletes. Comparison with still active athletes of the same ages. Circulation. 38(6):1968;1104-1115.
28. Nordt T.K., Peter K., Ruef J., Kubler W., Bode C. Plasminogen activator inhibitor type-1 (PAI-1) and its role in cardiovascular disease. Thromb. Haemost. (Suppl. 1):1999;14-18.
29. Hauert J., Nicoloso G., Schleuning W.D., Bachmann F., Schapira M. Plasminogen activators in dextran sulfate-activated euglobulin fractions: a molecular analysis of factor XII and prekallikrein-dependent fibrinolysis. Blood. 73(4):1989;994-999.
30. Kohler H.P., Carter A.M., Stickland M.H., Grant P.J. Levels of activated FXII in survivors of myocardial infarction. Association with circulating risk factors and extent of coronary artery disease. Thromb. Haemost. 79(1):1998;14-18.
31. Miller G.J., Esnouf M.P., Burgess A.I., Cooper J.A., Mitchell J.P. Risk of coronary heart disease and activation of factor XII in middle-aged men. Arterioscler. Thromb. Vasc. Biol. 17(10):1997;2103-2106.
32. Thompson S.G., Fechtrup C., Squire E., Heyse U., Breithardt G., van de Loo J.C., et al. Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris. Arterioscler. Thromb. Vasc. Biol. 16(3):1996;357-362.
33. Fowkes F.G., Lowe G.D., Housley E., Rattray A., Rumley A., Elton R.A., et al. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet. 342:1993;84-86.
34. Junker R., Heinrich J., Schulte H., van de Loo J., Assmann G. Coagulation factor VII and the risk of coronary heart disease in healthy men. Arterioscler. Thromb. Vasc. Biol. 17(8):1997;1539-1544.
35. Gensini G.F., Comeglio M., Colella A. Classical risk factors and emerging elements in the risk profile for coronary artery disease. Eur. Heart J. 19(Suppl. A):1998;A53-A61.
36. Kario K., Matsuo T., Kobayashi H., Matsuo M., Sakata T., Miyata T., et al. Factor VII hyperactivity and endothelial cell damage are found in elderly hypertensives only when concomitant with microalbuminuria. Arterioscler. Thromb. Vasc. Biol. 16(3):1996;455-461.
37. Allemann Y., Weidmann P. Cardiovascular, metabolic and hormonal dysregulations in normotensive offspring of essential hypertensive parents. J. Hypertens. 13(12):1995;163-173.